US pharmaceutical company searched after potential link to fungal meningitis outbreak
US pharmaceutical company, the New England Compounding Center (NECC), is being investigated after a suggested link to a multi-state fungal meningitis outbreak in the US.
The NECC was raided after the FDA raised concerns about sterility and cleanliness at the NECC.
Doctors have been warned not to prescribe any of the company's products, after 16 deaths from a rare fungal form of meningitis, allegedly after using contaminated steroid and heart drugs from the NECC. In total, over 200 people in the US have been affected.
Criminal investigators from the Department of Justice and the FDA were at the Massachusetts pharmaceutical company yesterday with a search warrant.
Health officials have contacted 12,000 of the approximate 14,000 people who have received the steroid shots.